George Mosialos

8.1k total citations · 2 hit papers
71 papers, 6.7k citations indexed

About

George Mosialos is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, George Mosialos has authored 71 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 29 papers in Molecular Biology and 29 papers in Cancer Research. Recurrent topics in George Mosialos's work include NF-κB Signaling Pathways (29 papers), Viral-associated cancers and disorders (28 papers) and Lymphoma Diagnosis and Treatment (17 papers). George Mosialos is often cited by papers focused on NF-κB Signaling Pathways (29 papers), Viral-associated cancers and disorders (28 papers) and Lymphoma Diagnosis and Treatment (17 papers). George Mosialos collaborates with scholars based in United States, Greece and United Kingdom. George Mosialos's co-authors include Elliott Kieff, Eudoxia Hatzivassiliou, Kenneth M. Izumi, Carl F. Ware, Eirini Trompouki, Todd Van Arsdale, Hannah Farmer, Alan Ashworth, Kenneth M. Kaye and Odile Devergne and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

George Mosialos

69 papers receiving 6.6k citations

Hit Papers

The Epstein-Barr virus transforming protein LMP1 engages ... 1995 2026 2005 2015 1995 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
    1995 839 citations George Mosialos, Todd Van Arsdale et al. Cell profile →
  2. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
    2003 788 citations Eirini Trompouki, Eudoxia Hatzivassiliou et al. Nature profile →

Peers

George Mosialos
Pierre Busson France
Paul G. Murray United Kingdom
Martin J. Allday United Kingdom
Vu N. Ngo United States
Tetsuya Nosaka Japan
Harlan Robins United States
Wolfgang Hammerschmidt Germany
Bo Zhao United States
Richard R. Hardy United States
Jeffrey Sklar United States
Pierre Busson France
George Mosialos
Citations per year, relative to George Mosialos George Mosialos (= 1×) peers Pierre Busson

Countries citing papers authored by George Mosialos

Since Specialization
Citations

This map shows the geographic impact of George Mosialos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Mosialos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Mosialos more than expected).

Fields of papers citing papers by George Mosialos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Mosialos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Mosialos. The network helps show where George Mosialos may publish in the future.

Co-authorship network of co-authors of George Mosialos

This figure shows the co-authorship network connecting the top 25 collaborators of George Mosialos. A scholar is included among the top collaborators of George Mosialos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Mosialos. George Mosialos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mukherjee, Sandip, Ritesh Kumar, Venkatesha Basrur, et al.. (2020). Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation. Nature Immunology. 21(6). 626–635. 82 indexed citations
2.
Angelopoulou, Katerina, Alexandros Hardas, Kali Makedou, et al.. (2020). <p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>. OncoTargets and Therapy. Volume 13. 5575–5588. 19 indexed citations
3.
Gravato‐Nobre, Maria J., et al.. (2018). Functional analysis of the C. elegans cyld-1 gene reveals extensive similarity with its human homolog. PLoS ONE. 13(2). e0191864–e0191864. 4 indexed citations
4.
Orfanidou, Timoklia, et al.. (2017). Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells. Anticancer Research. 37(7). 3493–3503. 14 indexed citations
5.
Jin, Yingai J., et al.. (2016). Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors. JCI Insight. 1(11). 13 indexed citations
6.
7.
Habelhah, Hasem, et al.. (2014). The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation. Cellular Signalling. 26(12). 2730–2737. 21 indexed citations
8.
9.
Nikolaou, Konstantin, Ageliki Tsagaratou, Christina Eftychi, et al.. (2012). Inactivation of the Deubiquitinase CYLD in Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, and Cancer. Cancer Cell. 21(6). 738–750. 113 indexed citations
10.
Tsagaratou, Ageliki, Dimitris L. Kontoyiannis, & George Mosialos. (2011). Truncation of the Deubiquitinating Domain of CYLD in Myelomonocytic Cells Attenuates Inflammatory Responses. PLoS ONE. 6(1). e16397–e16397. 6 indexed citations
11.
Demetriades, Constantinos, Alexander Polyzos, Aggelos Banos, et al.. (2011). Genomic Analysis Reveals a Novel Nuclear Factor-κB (NF-κB)-binding Site in Alu-repetitive Elements. Journal of Biological Chemistry. 286(44). 38768–38782. 46 indexed citations
12.
Tsagaratou, Ageliki, Sofia Grammenoudi, & George Mosialos. (2011). Differential requirement of IKK2 for CYLD‐dependent representation of thymic and peripheral T‐cell populations. European Journal of Immunology. 41(10). 3054–3062. 3 indexed citations
13.
14.
Trompouki, Eirini, Ageliki Tsagaratou, Stylianos Kosmidis, et al.. (2009). Truncation of the Catalytic Domain of the Cylindromatosis Tumor Suppressor Impairs Lung Maturation. Neoplasia. 11(5). 469–476. 40 indexed citations
15.
Trompouki, Eirini, et al.. (2003). CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature. 424(6950). 793–796. 788 indexed citations breakdown →
16.
Luftig, Micah A., Ellen Cahir-McFarland, George Mosialos, & Elliott Kieff. (2001). Effects of the NIK aly Mutation on NF-κB Activation by the Epstein-Barr Virus Latent Infection Membrane Protein, Lymphotoxin β Receptor, and CD40. Journal of Biological Chemistry. 276(18). 14602–14606. 38 indexed citations
17.
Izumi, Kenneth M., et al.. (1999). Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB. Oncogene. 18(49). 6959–6964. 142 indexed citations
18.
Xiao, Tong, Ronny Drapkin, Ramana R. Yalamanchili, George Mosialos, & Elliott Kieff. (1995). The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE. Molecular and Cellular Biology. 15(9). 4735–4744. 215 indexed citations
19.
Mosialos, George, et al.. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80(3). 389–399. 839 indexed citations breakdown →
20.
Bolton, W. Kline, George Mosialos, Saı̈d Sif, et al.. (1994). Characterization of a chicken cDNA encoding the retinoblastoma gene product. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1218(1). 82–86. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Busson Breakdown of academic impact, for papers by Paul G. Murray Breakdown of academic impact, for papers by Martin J. Allday Breakdown of academic impact, for papers by Vu N. Ngo Breakdown of academic impact, for papers by Tetsuya Nosaka Breakdown of academic impact, for papers by Harlan Robins Breakdown of academic impact, for papers by Wolfgang Hammerschmidt Breakdown of academic impact, for papers by Bo Zhao Breakdown of academic impact, for papers by Richard R. Hardy Breakdown of academic impact, for papers by Jeffrey Sklar
Rankless by CCL
2026